Position in LLY
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$11,055,144
+$2,837,924 QoQ
Shares Held
9,217
+3.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
2.78%
of 13F equity value
Holder Rank
#1,205
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 28%
Shared 72%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SOMERVILLE KURT F holds $31,801,956 across 8 Drug Manufacturers - General names. LLY ranks #2 (34.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
58,877 | $14,952,986 | |
| 2 | LLY |
ELI LILLY & Co
This page
|
9,217 | $11,055,144 | |
| 3 | MRK |
Merck & Co., Inc.
|
15,539 | $1,996,761 | |
| 4 | NVS |
Novartis AG
|
10,438 | $1,635,841 | |
| 5 | ABBV |
AbbVie Inc.
|
5,261 | $1,323,877 | |
| 6 | AMGN |
Amgen Inc
|
1,057 | $382,760 | |
| 7 | NVO |
Novo Nordisk A S
|
4,825 | $231,310 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
3,875 | $223,277 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,055,144 | 9,217 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $8,217,220 | 8,934 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $12,076,176 | 11,237 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $7,044,016 | 9,232 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $5,645,353 | 7,242 | Shares | Sole | 2025-07-23 | |
| 2025-03-31 | $3,473,775 | 4,206 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $2,865,664 | 3,712 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $3,386,062 | 3,822 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $3,576,251 | 3,950 | Shares | Defined | 2024-08-12 | |
| 2024-03-31 | $3,314,108 | 4,260 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $2,707,662 | 4,645 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,600,245 | 4,841 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $2,352,402 | 5,016 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $1,779,257 | 5,181 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $2,003,339 | 5,476 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $1,786,831 | 5,526 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $1,793,315 | 5,531 | Shares | Sole | 2022-07-19 | |
| 2022-03-31 | $1,630,876 | 5,695 | Shares | Sole | 2022-05-17 | |
| 2021-12-31 | $1,604,837 | 5,810 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $1,329,692 | 5,755 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $1,390,890 | 6,060 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $1,132,128 | 6,060 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $1,056,937 | 6,260 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $926,604 | 6,260 | Shares | Sole | 2020-10-28 | |
| 2020-06-30 | $1,056,497 | 6,435 | Shares | Sole | 2020-07-28 | |
| 2020-03-31 | $908,615 | 6,550 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||